Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine
NCT05374317
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
88
Enrollment
FED
Sponsor class
Conditions
Yellow Fever Vaccination Reaction
Interventions
BIOLOGICAL:
Yellow Fever Vaccine
Sponsor
US Army Medical Research Institute of Infectious Diseases